Cargando…
In Silico Investigations of Multi-Drug Adaptive Therapy Protocols
SIMPLE SUMMARY: Modern “adaptive therapy” approaches to cancer therapy rely on adjusting the dose of drugs as the size of the tumor changes. They hold the promise of transforming cancer from an acute lethal disease to a chronic disease we could live with, but not die from. Previous adaptive therapy...
Autores principales: | Thomas, Daniel S., Cisneros, Luis H., Anderson, Alexander R. A., Maley, Carlo C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179496/ https://www.ncbi.nlm.nih.gov/pubmed/35681680 http://dx.doi.org/10.3390/cancers14112699 |
Ejemplares similares
-
Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer
por: Seyedi, Sareh, et al.
Publicado: (2023) -
Cell-in-cell phenomena across the tree of life
por: Kapsetaki, Stefania E., et al.
Publicado: (2023) -
Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease
por: Sierra, Beatriz, et al.
Publicado: (2021) -
An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei
por: Alshabrmi, Fahad M., et al.
Publicado: (2022) -
Evaluation of a Commercial Multiplex PCR for Rapid Detection of Multi Drug Resistant Gram Negative Infections
por: Chavada, Ruchir, et al.
Publicado: (2015)